Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cellsThomas W. Grunt, Christian Dittrich, E. Dittrich et al.|International Journal of Cancer|1995Cited by 70
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cellsDaniel Veigel, Thomas W. Grunt|International Journal of Cancer|2014Cited by 62
Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cellsRenate Wagner, Thomas W. Grunt|Oncotarget|2017Cited by 57
Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cellsKarin Bauer, Thomas W. Grunt|Oncotarget|2018Cited by 28
Pharmacological Inhibition of Lipid Import and Transport Proteins in Ovarian CancerLisa Lemberger, Thomas W. Grunt|Cancers|2022Cited by 10